ABCD² Stroke Risk Score Calculator

Estimate the short-term risk of stroke following a transient ischaemic attack (TIA). The ABCD² score helps guide urgent assessment and treatment decisions as recommended by NICE NG128.

Important Clinical Disclaimer: The ABCD² score is intended for use by qualified healthcare professionals only. It is for educational and informational purposes and should not replace clinical judgement. Always interpret results alongside the full clinical picture and follow your local guidelines and protocols.
ABCD² Assessment

Blood pressure at initial evaluation

Symptoms at presentation

About the ABCD² Score

The ABCD² score is a validated clinical prediction tool that estimates the short-term risk of stroke following a transient ischaemic attack (TIA). It helps clinicians prioritise patients for urgent investigation and treatment.

What ABCD² Stands For:
  • A - Age (≥60 years = 1 point)
  • B - Blood pressure (≥140/90 = 1 point)
  • C - Clinical features (weakness = 2, speech = 1)
  • D - Duration of symptoms
  • D - Diabetes (if present = 1 point)
When to Use:
  • After a suspected or confirmed TIA
  • To guide urgency of specialist assessment
  • To inform patient counselling about stroke risk

ABCD² Score Interpretation

Score Risk Level 2-Day Risk 7-Day Risk Recommended Action
0-3 Low risk ~1.0% ~1.2%
  • Specialist assessment within 24 hours (per NICE NG128)
  • Initiate secondary prevention
  • Consider outpatient management if seen promptly
4-5 Moderate risk ~4.1% ~5.9%
  • Specialist assessment within 24 hours
  • Urgent brain imaging (CT/MRI)
  • Carotid imaging if anterior circulation symptoms
  • Immediate secondary prevention
6-7 High risk ~8.1% ~11.7%
  • Immediate specialist assessment
  • Consider admission to stroke unit
  • Urgent brain and vascular imaging
  • Immediate antiplatelet therapy
  • Address modifiable risk factors urgently
NICE Guidance (NG128):

NICE recommends that all people with suspected TIA should be assessed urgently by a stroke specialist within 24 hours of symptom onset, regardless of ABCD² score. The score should not be used alone to determine who needs urgent assessment - it is one factor among many in clinical decision-making.

Important Considerations

High-Risk Features (Regardless of Score)

Some patients require immediate assessment even with low ABCD² scores:

  • Crescendo TIAs (2 or more TIAs in a week)
  • TIA on anticoagulation
  • Known severe carotid stenosis
  • AF-related TIA (high recurrence risk)
  • Ongoing or very recent symptoms
  • TIA mimics requiring urgent exclusion (e.g., hypoglycaemia, seizure)
Urgent Investigations

Standard workup for suspected TIA includes:

  • Brain imaging - CT or MRI (diffusion-weighted)
  • Carotid imaging - Duplex ultrasound or CT/MR angiography
  • ECG - to detect AF
  • Blood tests - FBC, U&Es, glucose, lipids, HbA1c
  • Cardiac monitoring - if AF suspected
  • Echocardiography - in selected cases

Limitations

Limitations of the ABCD² Score
  • Moderate predictive accuracy - some high-risk patients will score low
  • Does not account for imaging findings (e.g., DWI-positive lesions)
  • Does not include aetiology - large artery disease carries higher risk
  • Derived from older cohorts - risk estimates may not reflect current practice
  • Cannot identify TIA mimics
  • Less validated in younger patients
Enhanced Scores (ABCD²-I, ABCD3-I)

Extended versions include additional predictors:

  • ABCD²-I - adds imaging (DWI lesion = +2)
  • ABCD3 - adds dual TIA (TIA within 7 days = +2)
  • ABCD3-I - combines both additions

These enhanced scores may improve risk stratification but are not universally adopted in UK practice.

Frequently Asked Questions

A transient ischaemic attack (TIA) is a temporary interruption of blood flow to part of the brain, causing stroke-like symptoms that resolve completely within 24 hours (typically within minutes to an hour). The modern definition focuses on the absence of tissue injury (no infarction on imaging) rather than a strict time limit.

TIA is a medical emergency because it indicates a high risk of subsequent stroke - hence the term "warning stroke" or "mini-stroke."

The ABCD² score has moderate predictive accuracy with a c-statistic of approximately 0.62-0.72 in validation studies. This means it is better than chance but not highly discriminating.

Importantly, some studies have shown that a significant proportion of patients who go on to have strokes have low ABCD² scores. This is why NICE recommends urgent assessment for all suspected TIA patients regardless of score.

Yes. Current NICE guidance (NG128) recommends that all people with suspected TIA should receive:

  • Specialist assessment within 24 hours of symptom onset
  • Immediate treatment with aspirin 300mg (unless contraindicated)
  • Brain imaging and vascular assessment

The ABCD² score should inform clinical decision-making but should not be the sole determinant of urgency.

While awaiting specialist assessment, NICE recommends:

  • Aspirin 300mg immediately (if not contraindicated and haemorrhage excluded)
  • Continue aspirin until seen by specialist
  • Specialist will typically initiate dual antiplatelet therapy (aspirin + clopidogrel) for 21 days
  • High-intensity statin therapy
  • Blood pressure management

Early treatment significantly reduces the risk of subsequent stroke.

Several extended versions of the score exist:

  • ABCD²-I - incorporates MRI diffusion-weighted imaging findings
  • ABCD3 - adds history of TIA in previous 7 days
  • ABCD3-I - combines both additional factors

These extended scores may offer slightly better discrimination but require additional investigations. In UK practice, the original ABCD² remains widely used alongside clinical judgement.

Disclaimer

This calculator is provided for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

  • Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
  • Never disregard professional medical advice or delay seeking it because of information from this tool.
  • Clinical decision-making should always incorporate the full clinical context, patient preferences, and local protocols.
  • The creators of this tool accept no liability for decisions made based on its output.

If you are a patient: please discuss any results with your healthcare provider. This tool is designed for use by medical professionals and may not be appropriate for self-assessment.

References

  1. Johnston SC, et al. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet, 369(9558), 283-292.
  2. NICE (2019). Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128).
  3. Rothwell PM, et al. (2005). A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet, 366(9479), 29-36.
  4. Giles MF, Rothwell PM. (2007). Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurology, 6(12), 1063-1072.
  5. Intercollegiate Stroke Working Party. (2023). National Clinical Guideline for Stroke for the UK and Ireland.